Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Spencer Frost"'
Pentosan Polysulfate–Associated Dysplasia in Patients With Inflammatory Bowel Disease: A Case Series
Publikováno v:
American Journal of Gastroenterology. 118:905-908
Autor:
Catherine A. Hogan, Matthew M. Hitchcock, Spencer Frost, Kristopher Kapphahn, Marisa Holubar, Lucy S. Tompkins, Niaz Banaei
Publikováno v:
J Clin Microbiol
Clostridioides difficile infection (CDI) is routinely diagnosed by PCR, with or without toxin enzyme immunoassay testing. The role of therapy for positive PCR and negative toxin remains unclear. The objective of this study was to determine whether cl
Autor:
Catherine A. Hogan, Matthew M. Hitchcock, Spencer Frost, Kristopher Kapphahn, Marisa Holubar, Lucy S. Tompkins, Niaz Banaei
Publikováno v:
Journal of Clinical Microbiology. 60
Clostridioides difficile infection (CDI) is routinely diagnosed by PCR, with or without toxin enzyme immunoassay testing. The role of therapy for positive PCR and negative toxin remains unclear.
Publikováno v:
Gastroenterology. 164:S36
BACKGROUND Pentosan polysulfate is used for symptomatic management of interstitial cystitis. At one institution we incidentally noted six patients who were on this agent and had a diagnosis of inflammatory bowel disease (IBD). Three of these patients
Publikováno v:
Journal of clinical gastroenterology.
Perianal Crohn's disease (pCD) represents an aggressive phenotype with limited studies on long-term outcomes. We evaluated 5-year outcomes of these patients on biologic therapies.We performed a retrospective analysis of patients with pCD at a tertiar
Publikováno v:
American Journal of Gastroenterology. 117:S15-S15
Publikováno v:
American Journal of Gastroenterology. 116:S354-S354
Autor:
Michael Estep, Elena Younossi, Linda Henry, Nayeem Hossain, Sharon L. Hunt, Zachary Goodman, Yun Fang, Zobair M. Younossi, Spencer Frost, Munkhzul Otgonsuren
Publikováno v:
Journal of Gastroenterology and Hepatology. 29:2006-2013
Background and Aim Non-alcoholic steatohepatitis (NASH) is the progressive form of non-alcoholic fatty liver disease (NAFLD). A liver biopsy is considered the “gold standard” for diagnosing/staging NASH. Identification of NAFLD/NASH using non-inv
Autor:
Spencer Frost, Maria Stepanova, Shirley Kalwaney, Zobair M. Younossi, S. Clement, Sammy Saab, Linda Henry, Sharon L. Hunt
Publikováno v:
Alimentary Pharmacology & Therapeutics. 40:686-694
Summary Background Type 2 diabetes is known to negatively impact the outcome of chronic liver disease. Aim To evaluate the impact of diabetes on the outcomes of liver transplants (LT). Methods Study cohort included adults (>18 years) who received LT
Publikováno v:
Infectious Diseases in Clinical Practice. 26:331-332